Intranasal Vaccine Administration
Intranasal administration of vaccines has recently proven to be
one of the most efficient ways for inducing both mucosal and
systemic antibody responses in experimental animals. The needle-free
nature of nasal delivery also offers hopes of improved patient compliance.
In recent testing at the Center for Disease Control and Prevention, three
different ViaNase device configurations aerosolized live attenuated
measles virus without loss of potency.